UBR5 regulates the progression of colorectal cancer cells through Snail-induced epithelial-mesenchymal transition

Xinyue Zhao1, Ruiying Liu1, Zhihui Han1

  • 1Edmond H. Fischer Signal Transduction Laboratory, School of Life Sciences, Jilin University, Changchun, Jilin 130012, China.

Genes & Diseases
|January 6, 2026
PubMed

Insights

The E3 ubiquitin ligase UBR5 degrades Snail, a key inducer of epithelial-to-mesenchymal transition (EMT). This UBR5-Snail interaction inhibits colorectal cancer progression and metastasis.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Snail is a crucial transcription factor that drives epithelial-to-mesenchymal transition (EMT), a process implicated in cancer progression and metastasis.
  • Understanding the post-translational regulation of Snail is essential for developing targeted cancer therapies.

Purpose of the Study:

  • To investigate the role of UBR5 (a ubiquitin ligase) in regulating Snail protein stability and its impact on colorectal cancer (CRC) progression.
  • To elucidate the molecular mechanism by which UBR5 controls Snail and its downstream effects on EMT and CRC metastasis.

Main Methods:

  • In vitro binding assays to assess UBR5-Snail interaction.
  • Western blotting to analyze Snail protein levels upon UBR5 modulation (depletion or overexpression).
  • Cellular assays to evaluate EMT markers, cell invasion, and tumor progression in colorectal cancer cells.
  • Analysis of UBR5 expression in human colorectal cancer tissues and correlation with patient prognosis.

Main Results:

  • UBR5 directly binds to Snail and promotes its ubiquitin-mediated degradation, a process dependent on Snail phosphorylation.
  • Depletion of UBR5 leads to Snail accumulation, enhanced EMT, and increased invasion in colorectal cancer cells.
  • Overexpression of UBR5 reduces Snail levels and cellular invasiveness, while an inactive UBR5 mutant fails to regulate Snail and EMT.
  • UBR5 is downregulated in colorectal cancer tissues, and its high expression correlates with a better prognosis.

Conclusions:

  • The UBR5-Snail axis represents a novel mechanism for post-translational regulation of EMT in colorectal cancer.
  • UBR5 acts as a tumor suppressor by degrading Snail, thereby inhibiting EMT and metastasis in colorectal cancer.
  • UBR5 levels can serve as a prognostic biomarker in colorectal cancer, with higher expression indicating a more favorable outcome.

Related Concept Videos

Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.4K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.
2.6K